📰 ET Markets 🟢 BULLISH 🕒 27 Oct 2026, 12:55 PM IST

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

⚡ Instant Key Takeaways (TL;DR)

🎯

Core Development: Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

📊

Market & Financial Impact: Mankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, supported by domestic and export growth, while EBITDA margins expanded 210 basis points.

💡

Actionable Insight: 🟢 Bullish Trigger: Positive business expansion or earnings beat may attract institutional and retail buying.

Strong domestic demand, export growth and improved margins powered Mankind Pharma’s September-quarter performance.

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

KYC and KYB: Inside Damani’s Avenue Supermarts that refuses to charge more – Part 1 of 3

Will oil turn into a lingering problem? Is the world economy, India, or the market prepared?

📰

Official Publisher Attribution: This report is aggregated from Economic Times. ZeroLive provides live aggregation, automated sentiment synthesis, and exchange disclosure monitoring for retail market participants.

Read Original Full Coverage on Economic Times ↗

⚡

Get Breaking Stock Alerts & Q-Results on Telegram

Real-time 1200x675 image cards and financial filings delivered instantly.

Join @Zerolive_news ↗

Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore

🔥 More Live Market Stories

Cipla Q2 results: Net profit plunges 35% to Rs 878 crore, revenue falls 2.4% YoY

[CIPLA] Investor Presentation - Cipla Limited

Sensex falls 400 pts from day's high, Nifty below 22,700: Key reasons behind market decline

Jio Financial Services share price decoded: Reliance stock performance amid Jio Platforms IPO buzz; target, outlook

[CIPLA] Press Release - Cipla Limited

[BHARATSE] Outcome of Board Meeting - Bharat Seats Limited